Delivery Order SPE2DB20D3103-SPE2DB24FP9P5
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,951.32 firm fixed-price contract is for the delivery of valganciclovir hydrochloride 50 mg/mL oral solution. The ultimate completion date is November 14, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $22,542.94 and provides for the delivery of Valganciclovir HCL 50 mg/ml 88ml, a pharmaceutical product, through January 23, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the provision of VALGANCICLOVIR HCL 50 MG/ML 88ML to the Defense Logistics Agency (DLA). The contract, valued at $1,090.78, is a firm fixed-price delivery order with a completion date of June 20, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,372.02 Firm Fixed Price Delivery Order is for the supply of Valganciclovir Hydrochloride 50 mg/mL 88 mL medication. The contract has an ultimate completion date of September 3, 2024. No set-aside was used for this award. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This federal contract award is for the delivery of valganciclovir hydrochloride 50 mg/ml oral solution, with a ceiling value of $1,194.87. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 26, 2024 and is structured as a firm fixed-price delivery order. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.08 firm fixed-price delivery order is for the supply of 4563033480 - Valganciclovir HCL 50 MG/ML 88ML, with a period of performance ending on December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,761.30 firm fixed price delivery order is for the supply of 60 doses of the pharmaceutical product Valganciclovir 450 mg tablets. The contract has no set-aside designation and the period of performance runs through January 25, 2024. Amerisourcebergen Drug Corp is a prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The $8,386.87 firm fixed-price delivery order is for 60 tablets of the medication valganciclovir 450 mg. The contract has a period of performance through July 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,530.43, is for the delivery of 60 tablets of valganciclovir 450 mg. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has a completion date of March 12, 2025 and was awarded on March 11, 2025. This award is not designated as a set-aside contract....